NON-SMALL CELL LUNG ADENOCARCINOMA

Clinical trials for NON-SMALL CELL LUNG ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL CELL LUNG ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NON-SMALL CELL LUNG ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough cancers: first human test of experimental drug begins

Disease control Recruiting now

This is the first study in people to test a new drug called NXP900 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. The study will also look for early signs that the drug can shrink tumors, especially in cancers with speci…

Matched conditions: NON-SMALL CELL LUNG ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

NON-SMALL CELL LUNG ADENOCARCINOMA

Get alerted when new NON-SMALL CELL LUNG ADENOCARCINOMA trials appear

New hope for tough cancers: first human test of experimental drug begins